• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Vitamin supplementation for preventing miscarriage.预防流产的维生素补充剂
Cochrane Database Syst Rev. 2016 May 6;2016(5):CD004073. doi: 10.1002/14651858.CD004073.pub4.
2
Vitamin supplementation for preventing miscarriage.维生素补充剂预防流产
Cochrane Database Syst Rev. 2011 Jan 19(1):CD004073. doi: 10.1002/14651858.CD004073.pub3.
3
Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy.在怀孕前或怀孕早期开始补钙,或对食物进行钙强化,以预防妊娠期高血压疾病。
Cochrane Database Syst Rev. 2017 Sep 26;9(9):CD011192. doi: 10.1002/14651858.CD011192.pub2.
4
Vitamin supplementation for preventing miscarriage.预防流产的维生素补充剂
Cochrane Database Syst Rev. 2005 Apr 18(2):CD004073. doi: 10.1002/14651858.CD004073.pub2.
5
Multiple-micronutrient supplementation for women during pregnancy.孕期女性的多种微量营养素补充
Cochrane Database Syst Rev. 2017 Apr 13;4(4):CD004905. doi: 10.1002/14651858.CD004905.pub5.
6
Vitamin D supplementation for women during pregnancy.孕期女性补充维生素D
Cochrane Database Syst Rev. 2016 Jan 14(1):CD008873. doi: 10.1002/14651858.CD008873.pub3.
7
Intermittent oral iron supplementation during pregnancy.孕期间歇性口服铁补充剂。
Cochrane Database Syst Rev. 2012 Jul 11;7(7):CD009997. doi: 10.1002/14651858.CD009997.
8
Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.用于预防年龄相关性黄斑变性的抗氧化维生素和矿物质补充剂。
Cochrane Database Syst Rev. 2017 Jul 30;7(7):CD000253. doi: 10.1002/14651858.CD000253.pub4.
9
Progestogens for preventing miscarriage: a network meta-analysis.孕激素预防流产的作用:网状荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD013792. doi: 10.1002/14651858.CD013792.pub2.
10
Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.不明病因复发性流产女性预防流产的孕激素治疗
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD003511. doi: 10.1002/14651858.CD003511.pub6.

引用本文的文献

1
Folic Acid Supplementation and Risk of Gestational Diabetes Mellitus: A Systematic Review of the Literature.补充叶酸与妊娠期糖尿病风险:文献系统评价
Int J Mol Sci. 2025 Aug 18;26(16):7977. doi: 10.3390/ijms26167977.
2
Systematic Evaluation of How Indicators of Inequity and Disadvantage Are Measured and Reported in Population Health Evidence Syntheses.人口健康证据综合研究中不平等和劣势指标测量与报告方式的系统评价
Int J Environ Res Public Health. 2025 May 29;22(6):851. doi: 10.3390/ijerph22060851.
3
Effect of prednisolone on live birth rate in women with unexplained recurrent pregnancy loss: a study protocol for a double-blind, placebo-controlled, multicentre, randomised controlled trial (PREMI-study).泼尼松龙对不明原因复发性流产女性活产率的影响:一项双盲、安慰剂对照、多中心随机对照试验的研究方案(PREMI研究)
BMJ Open. 2025 Jun 19;15(6):e096545. doi: 10.1136/bmjopen-2024-096545.
4
Maternal Vitamin C Deficiency and Genetic Risk Factors Contribute to Congenital Defects through Dysregulation of DNA Methylation.母体维生素C缺乏和遗传风险因素通过DNA甲基化失调导致先天性缺陷。
bioRxiv. 2025 May 30:2025.05.27.656260. doi: 10.1101/2025.05.27.656260.
5
Randomized controlled trial of 4.0 mg versus 0.4 mg folic acid supplementation: Follow-up of children at 1 year of age.4.0毫克与0.4毫克叶酸补充剂的随机对照试验:1岁儿童随访
Eur J Obstet Gynecol Reprod Biol X. 2025 Feb 4;25:100370. doi: 10.1016/j.eurox.2025.100370. eCollection 2025 Mar.
6
Antioxidant therapy for infertile couples: a comprehensive review of the current status and consideration of future prospects.不育夫妇的抗氧化治疗:现状综合综述及未来前景考量
Front Endocrinol (Lausanne). 2025 Jan 9;15:1503905. doi: 10.3389/fendo.2024.1503905. eCollection 2024.
7
Associations of Maternal Nutritional Status and Supplementation with Fetal, Newborn, and Infant Outcomes in Low-Income and Middle-Income Settings: An Overview of Reviews.在中低收入国家和地区,母亲营养状况和补充剂与胎儿、新生儿和婴儿结局的关系:系统评价概述。
Nutrients. 2024 Oct 31;16(21):3725. doi: 10.3390/nu16213725.
8
Nutraceuticals in Pregnancy: A Special Focus on Probiotics.孕期营养补充剂:特别关注益生菌。
Int J Mol Sci. 2024 Sep 7;25(17):9688. doi: 10.3390/ijms25179688.
9
Mass spectrometry of water-soluble vitamins to establish a risk model for predicting recurrent spontaneous abortion.采用水溶性维生素的质谱分析来建立一个风险模型,以预测复发性自发性流产。
Sci Rep. 2024 Sep 6;14(1):20830. doi: 10.1038/s41598-024-71986-z.
10
Consensus Statements for Assessment and Management of Threatened Miscarriage in the First Trimester in Pakistan: A Three-Step Modified Delphi Approach.巴基斯坦孕早期先兆流产评估与管理的共识声明:三步改良德尔菲法
Cureus. 2024 Jul 22;16(7):e65079. doi: 10.7759/cureus.65079. eCollection 2024 Jul.

本文引用的文献

1
Maternal multiple micronutrient supplementation and other biomedical and socioenvironmental influences on children's cognition at age 9-12 years in Indonesia: follow-up of the SUMMIT randomised trial.印度尼西亚母婴多维元素补充及其他生物医学和社会环境因素对儿童 9-12 岁认知能力的影响:SUMMIT 随机试验随访。
Lancet Glob Health. 2017 Feb;5(2):e217-e228. doi: 10.1016/S2214-109X(16)30354-0.
2
Effects and safety of periconceptional oral folate supplementation for preventing birth defects.孕前口服叶酸补充剂预防出生缺陷的效果及安全性。
Cochrane Database Syst Rev. 2015 Dec 14;2015(12):CD007950. doi: 10.1002/14651858.CD007950.pub3.
3
Methyltetrahydrofolate vs Folic Acid Supplementation in Idiopathic Recurrent Miscarriage with Respect to Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms: A Randomized Controlled Trial.亚甲基四氢叶酸还原酶C677T和A1298C基因多态性相关的特发性复发性流产中甲基四氢叶酸与叶酸补充剂的比较:一项随机对照试验
PLoS One. 2015 Dec 2;10(12):e0143569. doi: 10.1371/journal.pone.0143569. eCollection 2015.
4
Multiple-micronutrient supplementation for women during pregnancy.孕期妇女补充多种微量营养素
Cochrane Database Syst Rev. 2015 Nov 1;2015(11):CD004905. doi: 10.1002/14651858.CD004905.pub4.
5
Vitamin A supplementation during pregnancy for maternal and newborn outcomes.孕期补充维生素A对孕产妇和新生儿结局的影响。
Cochrane Database Syst Rev. 2015 Oct 27;2015(10):CD008666. doi: 10.1002/14651858.CD008666.pub3.
6
The relative influence of maternal nutritional status before and during pregnancy on birth outcomes in Vietnam.越南孕期及孕前母亲营养状况对分娩结局的相对影响。
Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:223-7. doi: 10.1016/j.ejogrb.2015.09.018. Epub 2015 Sep 28.
7
Effects of Prenatal Multiple Micronutrient Supplementation on Fetal Growth Factors: A Cluster-Randomized, Controlled Trial in Rural Bangladesh.孕期补充多种微量营养素对胎儿生长因子的影响:孟加拉国农村地区的一项整群随机对照试验
PLoS One. 2015 Oct 2;10(10):e0137269. doi: 10.1371/journal.pone.0137269. eCollection 2015.
8
Vitamin C supplementation in pregnancy.孕期补充维生素C
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD004072. doi: 10.1002/14651858.CD004072.pub3.
9
PP170. Prenatal vitamin C and E supplementation is associated with a reduction in placental abruption and preterm birth in smokers.PP170. 产前补充维生素C和E与降低吸烟者的胎盘早剥和早产风险相关。
Pregnancy Hypertens. 2012 Jul;2(3):331-2. doi: 10.1016/j.preghy.2012.04.281. Epub 2012 Jun 13.
10
Maternal nutrition influences angiogenesis in the placenta through peroxisome proliferator activated receptors: A novel hypothesis.母体营养通过过氧化物酶体增殖物激活受体影响胎盘血管生成:一个新假说。
Mol Reprod Dev. 2015 Oct;82(10):726-34. doi: 10.1002/mrd.22518. Epub 2015 Jul 6.

预防流产的维生素补充剂

Vitamin supplementation for preventing miscarriage.

作者信息

Balogun Olukunmi O, da Silva Lopes Katharina, Ota Erika, Takemoto Yo, Rumbold Alice, Takegata Mizuki, Mori Rintaro

机构信息

Department of Health Policy, National Center for Child Health and Development, Medical Building No. 2, Hongo Campus, 2-10-1 Okura, Tokyo, Tokyo, Japan, 157-8535.

出版信息

Cochrane Database Syst Rev. 2016 May 6;2016(5):CD004073. doi: 10.1002/14651858.CD004073.pub4.

DOI:10.1002/14651858.CD004073.pub4
PMID:27150280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7104220/
Abstract

BACKGROUND

Miscarriage is a common complication of pregnancy that can be caused by a wide range of factors. Poor dietary intake of vitamins has been associated with an increased risk of miscarriage, therefore supplementing women with vitamins either prior to or in early pregnancy may help prevent miscarriage.

OBJECTIVES

The objectives of this review were to determine the effectiveness and safety of any vitamin supplementation, on the risk of spontaneous miscarriage.

SEARCH METHODS

We searched the Cochrane Pregnancy and Childbirth Group Trials Register (6 November 2015) and reference lists of retrieved studies.

SELECTION CRITERIA

All randomised and quasi-randomised trials comparing supplementation during pregnancy with one or more vitamins with either placebo, other vitamins, no vitamins or other interventions. We have included supplementation that started prior to conception, periconceptionally or in early pregnancy (less than 20 weeks' gestation).

DATA COLLECTION AND ANALYSIS

Three review authors independently assessed trials for inclusion, extracted data and assessed trial quality. We assessed the quality of the evidence using the GRADE approach. The quality of evidence is included for numerical results of outcomes included in the 'Summary of findings' tables.

MAIN RESULTS

We included a total of 40 trials (involving 276,820 women and 278,413 pregnancies) assessing supplementation with any vitamin(s) starting prior to 20 weeks' gestation and reporting at least one primary outcome that was eligible for the review. Eight trials were cluster-randomised and contributed data for 217,726 women and 219,267 pregnancies in total.Approximately half of the included trials were assessed to have a low risk of bias for both random sequence generation and adequate concealment of participants to treatment and control groups. Vitamin C supplementation There was no difference in the risk of total fetal loss (risk ratio (RR) 1.14, 95% confidence interval (CI) 0.92 to 1.40, seven trials, 18,949 women; high-quality evidence); early or late miscarriage (RR 0.90, 95% CI 0.65 to 1.26, four trials, 13,346 women; moderate-quality evidence); stillbirth (RR 1.31, 95% CI 0.97 to 1.76, seven trials, 21,442 women; moderate-quality evidence) or adverse effects of vitamin supplementation (RR 1.16, 95% CI 0.39 to 3.41, one trial, 739 women; moderate-quality evidence) between women receiving vitamin C with vitamin E compared with placebo or no vitamin C groups. No clear differences were seen in the risk of total fetal loss or miscarriage between women receiving any other combination of vitamin C compared with placebo or no vitamin C groups. Vitamin A supplementation No difference was found in the risk of total fetal loss (RR 1.01, 95% CI 0.61 to 1.66, three trials, 1640 women; low-quality evidence); early or late miscarriage (RR 0.86, 95% CI 0.46 to 1.62, two trials, 1397 women; low-quality evidence) or stillbirth (RR 1.29, 95% CI 0.57 to 2.91, three trials, 1640 women; low-quality evidence) between women receiving vitamin A plus iron and folate compared with placebo or no vitamin A groups. There was no evidence of differences in the risk of total fetal loss or miscarriage between women receiving any other combination of vitamin A compared with placebo or no vitamin A groups. Multivitamin supplementation There was evidence of a decrease in the risk for stillbirth among women receiving multivitamins plus iron and folic acid compared iron and folate only groups (RR 0.92, 95% CI 0.85 to 0.99, 10 trials, 79,851 women; high-quality evidence). Although total fetal loss was lower in women who were given multivitamins without folic acid (RR 0.49, 95% CI 0.34 to 0.70, one trial, 907 women); and multivitamins with or without vitamin A (RR 0.60, 95% CI 0.39 to 0.92, one trial, 1074 women), these findings included one trial each with small numbers of women involved. Also, they include studies where the comparison groups included women receiving either vitamin A or placebo, and thus require caution in interpretation.We found no difference in the risk of total fetal loss (RR 0.96, 95% CI 0.93 to 1.00, 10 trials, 94,948 women; high-quality evidence) or early or late miscarriage (RR 0.98, 95% CI 0.94 to 1.03, 10 trials, 94,948 women; moderate-quality evidence) between women receiving multivitamins plus iron and folic acid compared with iron and folate only groups.There was no evidence of differences in the risk of total fetal loss or miscarriage between women receiving any other combination of multivitamins compared with placebo, folic acid or vitamin A groups. Folic acid supplementation There was no evidence of any difference in the risk of total fetal loss, early or late miscarriage, stillbirth or congenital malformations between women supplemented with folic acid with or without multivitamins and/or iron compared with no folic acid groups. Antioxidant vitamins supplementation There was no evidence of differences in early or late miscarriage between women given antioxidant compared with the low antioxidant group (RR 1.12, 95% CI 0.24 to 5.29, one trial, 110 women).

AUTHORS' CONCLUSIONS: Taking any vitamin supplements prior to pregnancy or in early pregnancy does not prevent women experiencing miscarriage. However, evidence showed that women receiving multivitamins plus iron and folic acid had reduced risk for stillbirth. There is insufficient evidence to examine the effects of different combinations of vitamins on miscarriage and miscarriage-related outcomes.

摘要

背景

流产是孕期常见的并发症,其可由多种因素引起。孕期维生素摄入不足与流产风险增加有关,因此在怀孕前或孕早期为女性补充维生素可能有助于预防流产。

目的

本综述的目的是确定补充任何维生素对自然流产风险的有效性和安全性。

检索方法

我们检索了Cochrane妊娠与分娩组试验注册库(2015年11月6日)以及检索到的研究的参考文献列表。

选择标准

所有比较孕期补充一种或多种维生素与安慰剂、其他维生素、不补充维生素或其他干预措施的随机和半随机试验。我们纳入了在受孕前、围孕期或孕早期(妊娠少于20周)开始的补充剂。

数据收集与分析

三位综述作者独立评估试验是否纳入,提取数据并评估试验质量。我们使用GRADE方法评估证据质量。证据质量包含在“结果总结”表中纳入的结局的数值结果中。

主要结果

我们共纳入了40项试验(涉及276,820名女性和278,413次妊娠),这些试验评估了妊娠20周前开始补充任何维生素并报告了至少一项符合本综述条件的主要结局。八项试验为整群随机试验,总共为217,726名女性和219,267次妊娠提供了数据。纳入试验中约一半被评估在随机序列生成以及对治疗组和对照组参与者的充分隐藏方面存在低偏倚风险。补充维生素C与维生素E组的女性相比,安慰剂组或不补充维生素C组的女性在总胎儿丢失风险(风险比(RR)1.14,95%置信区间(CI)0.92至1.40,七项试验,18,949名女性;高质量证据)、早期或晚期流产(RR 0.90,95%CI 0.65至1.26,四项试验,13,346名女性;中等质量证据)、死产(RR 1.31,95%CI 0.97至1.76,七项试验,21,442名女性;中等质量证据)或维生素补充剂的不良反应(RR 1.16,95%CI 0.39至3.41,一项试验,739名女性;中等质量证据)方面没有差异。与安慰剂组或不补充维生素C组相比,接受任何其他维生素C组合的女性在总胎儿丢失或流产风险方面没有明显差异。补充维生素A与补充铁和叶酸的维生素A组女性相比,安慰剂组或不补充维生素A组的女性在总胎儿丢失风险(RR 1.01,95%CI 0.61至1.66,三项试验,1640名女性;低质量证据)、早期或晚期流产(RR 0.86,95%CI 0.46至1.62,两项试验,1397名女性;低质量证据)或死产(RR 1.29,95%CI 0.57至2.91,三项试验,1640名女性;低质量证据)方面没有差异。与安慰剂组或不补充维生素A组相比,接受任何其他维生素A组合的女性在总胎儿丢失或流产风险方面没有差异的证据。补充多种维生素与仅补充铁和叶酸的组相比,接受多种维生素加铁和叶酸的女性中有证据表明死产风险降低(RR 0.92,95%CI 0.85至0.99,十项试验,79,851名女性;高质量证据)。尽管未补充叶酸的多种维生素组女性的总胎儿丢失率较低(RR 0.49,95%CI 0.34至0.70,一项试验,907名女性);以及补充有或没有维生素A的多种维生素组(RR 0.60,95%CI 0.39至0.92,一项试验,1074名女性),但这些发现每项试验涉及的女性数量较少。此外,它们包括比较组包括接受维生素A或安慰剂的女性的研究,因此在解释时需要谨慎。我们发现补充多种维生素加铁和叶酸的女性与仅补充铁和叶酸的组相比,在总胎儿丢失风险(RR 0.96,95%CI 0.93至1.00,十项试验,94,948名女性;高质量证据)或早期或晚期流产(RR 0.98,95%CI 0.94至1.03,十项试验,94,948名女性;中等质量证据)方面没有差异。与安慰剂、叶酸或维生素A组相比,接受任何其他多种维生素组合的女性在总胎儿丢失或流产风险方面没有差异的证据。补充叶酸与未补充叶酸组相比,补充叶酸(有或没有多种维生素和/或铁)的女性在总胎儿丢失、早期或晚期流产、死产或先天性畸形风险方面没有差异的证据。补充抗氧化剂维生素与低抗氧化剂组相比,补充抗氧化剂的女性在早期或晚期流产方面没有差异的证据(RR 1.12,95%CI 0.24至5.29,一项试验,110名女性)。

作者结论

在怀孕前或孕早期服用任何维生素补充剂并不能预防女性流产。然而,有证据表明接受多种维生素加铁和叶酸的女性死产风险降低。没有足够的证据来检验不同维生素组合对流产及与流产相关结局的影响。